Healthcare specialist Archimed has sold its stake in health ingredients company HIS for an enterprise value in excess of €25m, earning close to 2.5x its investment and generating an IRR of 400 per cent. The French company has been sold to Germany-headquartered natural ingredients group Döhler. ArchiMed purchased its stake in HIS as part of…
Primo is constantly looking for new talents willing to learn, grow and shape a better future in a dynamic, young and international environment.
Avec huit investissements à son actif, la société de private equity ArchiMed se donne encore deux belles années pour épuiser son premier fonds, Med 1, de 150 M€. Créée en 2014, ArchiMed investit uniquement dans la santé et cible des sociétés déjà profitables dont le chiffre d’affaires tourne autour de la dizaine de millions d’euros.…
ArchiMed has acquired four companies: French health ingredients providers HIS (Press release) and Fytexia (Press release); Polyplus (Press release), a maker of transfection reagents; and Micromed (Press release), a French-Italian neurodiagnostic company.
You can listen to Jayne Carrington, Customer and Propositions Director of RehabWorks, interviewed on Share Radio, discussing mental wellbeing in the workplace. Jayne discusses the impact of mental health issues in the workplace and the importance and options for organisations to support the health and wellbeing of their employees. Services such as employee assistance programmes, training for managers and post-trauma support have a positive impact.…
ArchiMed has acquired a majority control of RehabWorks as well as a minority stake in Primo Group s.r.l. Financial terms weren’t announced. U.K.-based RehabWorks is contracted by companies and insurers to manage therapy, rehabilitation, workforce reinsertion and other physical and mental health issues for employees. Primo, of Torino, Italy, operates retail dental clinics in that country.
To receive ArchiMed News, please complete the form below.